BRC Inc.
BRCC Consumer Defensive Packaged Foods
BRC Inc.’s revenue for fiscal 2025 (year ended December 2025) was $398.3 million, up 1.73% from fiscal 2024.
- Revenue
- +7.27%
- EPS
- 0.00%
- Free cash flow
- −141.4%
- Total debt
- −10.4%
Quarter to September 2026, against a year earlier
Follow BRCC
Alert me
BRC Inc. (BRCC) EV/Sales
As of 6 November 2026, BRC Inc. (BRCC) trades at a EV/Sales of 0.3×. Over the past ten years it has ranged from 0.0× (December 2021) to 123× (March 2022); the current reading is higher than 20% of that period. That is below the Packaged Foods industry median of 0.9× and below the Consumer Defensive sector median of 1.0×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.3× | (52.84%) |
| FY2024 | 0.7× | (8.59%) |
| FY2023 | 0.8× | (28.66%) |
| FY2022 | 1.1× | (98.20%) |
| FY2021 | 61.9× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 0.3× | (14.49%) |
| Jun 2026 | 0.4× | 27.97% |
| Mar 2026 | 0.3× | (19.96%) |
| Dec 2025 | 0.3× | (31.07%) |
| 19 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ENHA Enhanced Group Inc. compare | n/m |
| USNA USANA Health Sciences, Inc. compare | 0.2× |
| NATR Nature's Sunshine Products, Inc. compare | 0.2× |
| BRCC BRC Inc. | 0.3× |
| NAGE Niagen Bioscience, Inc. compare | 0.8× |
| OTLY Oatly Group AB Sponsored ADR compare | 0.8× |
| BGS B&G Foods, Inc. compare | 1.2× |
| LWAY Lifeway Foods, Inc. compare | 1.4× |
| PRE Prenetics Global Limited compare | 1.4× |
| Packaged Foods industry median | 0.9× |
| Consumer Defensive sector median | 1.0× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)